Coordinating Transformative Care in NHL
Chimeric antigen receptor T-cell (CAR-T) therapy has rapidly transformed the treatment landscape for B-cell non-Hodgkin lymphomas (NHL), offering durable clinical responses in historically difficult-to-treat populations. In particular, CD19-directed CAR-T therapies have emerged as a cornerstone for patients with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma (MCL).
As innovation accelerates, so too does the complexity of delivering these therapies. Pharmacists are uniquely positioned at the center of this evolution—bridging clinical, operational, and patient care domains to ensure safe, timely, and equitable access to CAR-T therapy.
Advancing Access in the Era of CAR-T Innovation
Opportunities to expand access to cellular therapies are growing, driven by several key developments:
- Increasing adoption of outpatient CAR-T delivery models
- Advancements in next-generation CAR-T constructs
- Efforts to reduce vein-to-vein time
- Innovations aimed at improving T-cell stemness and persistence
- Emergence of dual-targeting CAR-T therapies
These shifts require highly coordinated, multidisciplinary care models and pharmacists play a critical role in operationalizing these advances.
The Pharmacist as a Central Coordinator of CAR-T Therapy
Effective CAR-T delivery extends far beyond product selection. Pharmacists contribute across the entire care continuum, including:
Treatment Planning and Protocol Development
Pharmacists help translate evolving clinical evidence into institutional protocols, ensuring alignment with updated guidelines and emerging data across NHL subtypes.
Formulary and Operational Readiness
With new CAR-T therapies entering the landscape, pharmacists anticipate formulary considerations, evaluate product differences, and support institutional readiness for adoption.
Education and Patient Support
Pharmacists provide essential education to both patients and healthcare teams, helping set expectations around the CAR-T process, including:
- Lymphodepletion
- Infusion logistics
- Monitoring requirements
- Potential toxicities
Safety Management and Surveillance
From cytokine release syndrome (CRS) to neurotoxicity, pharmacists are instrumental in developing and implementing safety management strategies and ensuring appropriate therapeutic surveillance.
Care Coordination Across the Continuum
CAR-T therapy involves complex coordination before referral, during treatment, and post-infusion. Pharmacists help streamline communication between referring providers, treatment centers, and care teams to support continuity and optimize outcomes.
Translating Evidence into Practice
As the body of evidence supporting CAR-T therapy continues to evolve, pharmacists must stay current with:
- Updated clinical guidelines
- Emerging efficacy and safety data
- Expanding indications across NHL subtypes
Incorporating this knowledge into practice enables pharmacists to contribute meaningfully to treatment planning and to support broader, more equitable access to these transformative therapies.
Learn More: Pharmacy Consults on CAR-T Coordination
To support pharmacists in navigating this rapidly advancing space, the Pharmacy Consults activity, based on a recent live virtual symposium, offers expert-led, case-based discussions focused on real-world application.
This program highlights how pharmacists can:
- Optimize CAR-T coordination and workflow integration
- Enhance patient and staff education
- Address safety management challenges
- Prepare for the integration of novel CAR-T therapies
Through practical insights and conversational case reviews, participants will gain actionable strategies to elevate their role in CAR-T delivery for patients with NHL.
Key Learning Outcomes
Upon completion of this activity, participants will be better able to:
- Summarize updated guidelines and evidence supporting established and emerging CAR-T therapies in DLBCL, FL, and MCL
- Contribute to team-based protocols that facilitate treatment planning and expand access to CAR-T therapy
- Address practical aspects of care coordination, including education, safety management, and therapeutic surveillance throughout the CAR-T process
Discover how to optimize CAR-T coordination and improve patient outcomes in NHL explore the activity today.
Take Coordinating Transformative Care in NHL: Insights for Delivering CAR-T Therapy in the Era of Expanded Access and Therapeutic Innovation.
